4-Deep Brain Reconstruction

The 4-DBR consortium aims to develop a transplantable 4D reconstructed brain to regenerate neurological disorders, integrating advanced bioprinting and stimulation technologies for effective therapy.

Subsidie
€ 2.987.775
2022

Projectdetails

Introduction

The 4-Deep Brain Reconstruction, 4-DBR consortium aims at generating a brand-new technological approach to regenerate brain affections that occur in neurological disorders. With 180 million affected people and an economic burden of 798 billion euros/year, Europe needs a radical leap into the future.

Challenges in Brain Regeneration

The complexity of the human brain has condemned every past attempt at regeneration because incomplete technologies did not allow for a full recapitulation of the brain properties. Any one of them missing jeopardized the functionality of the whole. There can't be any incremental solution for brain damage; the technology must be all-in.

Project Focus

4-DBR will focus on developing an implantable 4D reconstructed brain able to recapitulate all brain properties. This includes:

  • A complex architecture of neuronal cells integrated into a complete blood circuitry.
  • An integrated opto-stimulator to induce correct specification and integration of neurons.

Technological Collaboration

4-DBR integrates 6 technological leaders from complementary fields who will unite to develop the components of reconstructed brains:

  1. Laser-assisted bioprinting of pre-differentiated neurons with their native decellularized brain matrix.
  2. Extrusion bioprinting of the vascular system.
  3. In vitro blood-brain barrier reconstruction.
  4. A tissue-integrated wireless-controlled stimulating optoelectrical chip.

These four components will then be combined into a transplantable reconstructed brain that will be tested in a small animal model of Huntington’s disease.

Timeline and Vision

While a first prototype will be delivered in 36 months, the vision unifying 4-DBR expands way further. Therefore, the project will put into action a strong dissemination and exploitation plan:

  • Horizontally, 4-DBR will ensure the uptake of the generated methods to strengthen Europe’s technological actors.
  • Vertically, 4-DBR will thrust the reconstructed brain approach up in the development ladder to potentially generate, in a 10-year span, a therapy to change the lives of many patients.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.987.775
Totale projectbegroting€ 2.987.775

Tijdlijn

Startdatum1-9-2022
Einddatum31-8-2025
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYERpenvoerder
  • POIETIS
  • VERIGRAFT AB
  • DANMARKS TEKNISKE UNIVERSITET
  • OSPEDALE SAN RAFFAELE SRL
  • UNIVERSITAT DE BARCELONA

Land(en)

SpainFranceSwedenDenmarkItaly

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

Revolutionary high-resolution human 3D brain organoid platform integrating AI-based analytics

The 3D-BrAIn project aims to develop a personalized bio-digital twin of the human brain using advanced organoid cultures and machine learning to enhance precision medicine for CNS disorders.

€ 1.998.347
EIC Pathfinder

Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration

BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.

€ 4.039.541
EIC Pathfinder

IMPROVING THE EFFECTIVENESS AND SAFETY OF EPIGENETIC EDITING IN BRAIN REGENERATION

REGENERAR aims to develop a non-viral delivery system to reprogram glial cells into neurons for treating CNS injuries, focusing on safety, targeting, and stakeholder collaboration.

€ 2.943.233
EIC Pathfinder

Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cord

Piezo4Spine aims to create a groundbreaking 3D bioprinted mesh therapy for spinal cord injury that enhances neural repair through targeted mechanotransduction and gene therapy.

€ 3.537.120
EIC Pathfinder

Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic learning

CROSSBRAIN aims to revolutionize brain condition treatment using implantable microbots for real-time, adaptive neuromodulation and sensing in rodent models of Parkinson's Disease and Epilepsy.

€ 4.034.074

Vergelijkbare projecten uit andere regelingen

ERC Starting...

Engineering human cortical brain organoid’s connections to restore brain functions

This project aims to restore functional neuronal networks in cortical brain lesions using 3D bioprinted human-specific hydrogels and cortical brain organoids for innovative therapeutic solutions.

€ 1.500.000
ERC Consolid...

4D Brain-Targeting Nanomedicines for Treating Neurodegeneration

This project aims to develop advanced 4D-brain-targeting nanoparticles using nanotechnology to effectively deliver treatments for neurodegenerative diseases across the blood-brain barrier.

€ 2.000.000
ERC Proof of...

A Digitally-Enabled Electroconductive Patient-Specific Stimulation Implant for Spinal Cord Injury

This project aims to develop a patient-specific 3D-printed neuromodulation implant to enhance neuron regrowth and restore function in spinal cord injury patients through targeted electrical stimulation.

€ 150.000
EIC Accelerator

Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation

CorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030.

€ 2.500.000
Mkb-innovati...

Humane mini-breinen voor R&D-toepassingen

Het project ontwikkelt een applicatie voor het kweken en analyseren van humane mini-breinen, ter vermindering van dierproeven.

€ 744.000